- Home
- ATAI vs PSEC Comparison
ATAI vs PSEC Comparison
Compare ATAI & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- PSEC
- Stock Information
- Founded
- ATAI 2018
- PSEC 2004
- Country
- ATAI Netherlands
- PSEC United States
- Employees
- ATAI N/A
- PSEC N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- PSEC Finance/Investors Services
- Sector
- ATAI Health Care
- PSEC Finance
- Exchange
- ATAI Nasdaq
- PSEC Nasdaq
- Market Cap
- ATAI 1.6B
- PSEC 1.3B
- IPO Year
- ATAI 2021
- PSEC 2004
- Fundamental
- Price
- ATAI $3.66
- PSEC $2.67
- Analyst Decision
- ATAI Strong Buy
- PSEC Sell
- Analyst Count
- ATAI 5
- PSEC 1
- Target Price
- ATAI $14.00
- PSEC $2.50
- AVG Volume (30 Days)
- ATAI 5.2M
- PSEC 3.7M
- Earning Date
- ATAI 11-12-2025
- PSEC 11-06-2025
- Dividend Yield
- ATAI N/A
- PSEC 20.38%
- EPS Growth
- ATAI N/A
- PSEC N/A
- EPS
- ATAI N/A
- PSEC N/A
- Revenue
- ATAI $3,018,000.00
- PSEC $680,752,000.00
- Revenue This Year
- ATAI $736.04
- PSEC N/A
- Revenue Next Year
- ATAI N/A
- PSEC N/A
- P/E Ratio
- ATAI N/A
- PSEC N/A
- Revenue Growth
- ATAI 811.78
- PSEC N/A
- 52 Week Low
- ATAI $1.15
- PSEC $2.52
- 52 Week High
- ATAI $6.75
- PSEC $4.88
- Technical
- Relative Strength Index (RSI)
- ATAI 26.67
- PSEC 44.65
- Support Level
- ATAI $3.72
- PSEC $2.69
- Resistance Level
- ATAI $4.65
- PSEC $2.92
- Average True Range (ATR)
- ATAI 0.35
- PSEC 0.09
- MACD
- ATAI -0.13
- PSEC 0.00
- Stochastic Oscillator
- ATAI 0.80
- PSEC 36.25
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.